Monoclonal Antibody Therapy and Interleukin-2 in Treating Patients With Metastatic Melanoma
This study has been completed.
Information provided by:
National Cancer Institute (NCI)
First received: April 7, 2003
Last updated: June 18, 2013
Last verified: August 2006
No Study Results Posted on ClinicalTrials.gov for this Study
|Study Status:||This study has been completed.|
|Study Completion Date:||August 2006|
|Estimated Primary Completion Date:||No date given|
Maker AV, Phan GQ, Attia P, Yang JC, Sherry RM, Topalian SL, Kammula US, Royal RE, Haworth LR, Levy C, Kleiner D, Mavroukakis SA, Yellin M, Rosenberg SA. Tumor regression and autoimmunity in patients treated with cytotoxic T lymphocyte-associated antigen 4 blockade and interleukin 2: a phase I/II study. Ann Surg Oncol. 2005 Dec;12(12):1005-16. Epub 2005 Oct 21.